The Middle East and Africa Fertility Services market will hit USD 3.49 Billion by 2030, supported by Dubai and Gulf fertility providers.

Fertility Services Market Analysis

The Middle East and Africa fertility services market stands out for its contrasts between highly advanced hubs in the Gulf and limited infrastructure in much of Sub-Saharan Africa, shaped by cultural sensitivities, regulatory differences, and demographic realities. The United Arab Emirates has positioned itself as a leading destination through centers like Fakih IVF in Abu Dhabi and Bourn Hall Fertility Clinic in Dubai, which was established as a branch of the pioneering UK institute. These facilities attract patients from Saudi Arabia, Kuwait, and Oman where religious and legal restrictions limit the use of donor gametes or surrogacy, showing how cross-border movement defines the patient journey. South Africa has developed one of the most progressive fertility landscapes in the region, with the Children’s Act regulating surrogacy and clinics such as Aevitas Fertility Clinic in Cape Town offering egg donation programs that are recognized internationally. Egypt, home to one of the earliest IVF successes in the Arab world during the mid-1980s, continues to operate a large number of clinics though affordability remains a barrier since most patients pay out of pocket. Rising rates of conditions like diabetes, obesity, and polycystic ovary syndrome in Gulf states are fueling infertility cases, while in Africa infections such as untreated sexually transmitted diseases and complications from unsafe abortions remain major causes. Insurance coverage is rare, though Bahrain and the UAE have begun partial reimbursement schemes. Fertility preservation is slowly gaining ground in cancer hospitals like King Hussein Cancer Center in Jordan, which offers egg and sperm banking to patients before treatment. The integration of AI embryo grading tools is beginning in Dubai clinics, while workforce shortages in embryology continue to constrain capacity in African countries. According to the research report "Middle East and Africa Fertility Services Market Reserach Report, 2030," published by Actual Market Reserach, the Middle East and Africa Fertility Services market is expected to reach a market size of more than USD 3.49 Billion by 2030.

In the Gulf, Dubai Healthcare City has become a magnet for fertility clinics expanding from Europe and the US, while Saudi Arabia has been encouraging local private investment in ART centers under its Vision 2030 healthcare reforms. South Africa remains a leader in egg donation and fertility tourism, with international patients traveling from the UK, Germany, and even China due to favorable regulations and strong donor availability. Pharmaceutical companies like Merck and Ferring dominate the supply of hormonal drugs across the region, while local distributors in Egypt and Nigeria provide consumables to clinics despite supply chain challenges. Legal and ethical debates are visible in countries like Lebanon, where diverse religious communities have varying views on assisted reproduction, while in Nigeria societal stigma still discourages many couples from seeking care openly. Benchmarking outcomes is inconsistent, but the South African Society of Reproductive Medicine and Gynaecological Endoscopy has created registries to monitor success rates, helping to build trust among patients. Financing remains a hurdle, leading some UAE banks to introduce specialized medical loans for IVF cycles, while in Africa non-governmental organizations are stepping in with subsidized programs for low-income patients. Data privacy has become a rising concern, especially in Gulf countries integrating genetic testing into IVF workflows, requiring compliance with national cybersecurity laws. Educational campaigns are expanding in Egypt and South Africa to normalize infertility discussions and promote early intervention, often supported by ministries of health. Meanwhile, feminist perspectives are gaining attention in North Africa where women’s groups advocate for broader access to ART regardless of marital status, a position that clashes with conservative cultural norms..

Market Dynamic



Market Drivers

Rising infertility rates linked to lifestyle and health conditions:In MEA, infertility is rising due to obesity, diabetes, and hormonal disorders such as PCOS, which are highly prevalent in Gulf countries. Environmental factors, including extreme heat and pollution, also play a role in reducing fertility among men and women. With strong cultural expectations for large families, these health challenges directly push couples to seek fertility treatments.

Expansion of advanced clinics in Gulf countries:The UAE, Saudi Arabia, and Qatar have invested heavily in modern healthcare infrastructure, including state-of-the-art fertility clinics. These centers often partner with global fertility groups, bringing advanced technologies such as ICSI, embryo freezing, and genetic testing into the region. Their presence attracts both local patients and international fertility tourists from nearby countries with stricter regulations.

Market Challenges

Legal and religious restrictions:Fertility treatments in MEA face complex legal and religious barriers. In several countries, gamete donation and surrogacy are restricted or outright banned due to cultural and religious principles. These limitations narrow the range of available services, forcing many patients to travel abroad for procedures such as donor egg IVF or surrogacy.

Unequal healthcare access across the region:While Gulf countries boast advanced fertility facilities, many parts of Africa and less affluent Middle Eastern nations lack the infrastructure to provide ART. Patients in rural and lower-income regions often cannot access modern fertility services, which creates a stark contrast between wealthy hubs like Dubai and underdeveloped healthcare systems in Sub-Saharan Africa.

Market Trends

Growth of fertility tourism into Gulf hubs:Dubai and Abu Dhabi are emerging as medical tourism destinations, attracting patients from Africa, South Asia, and neighboring Middle Eastern countries where treatments are either unavailable or illegal. Their global connectivity, modern clinics, and international specialists are fueling this trend, positioning the UAE as a regional leader in fertility tourism.

Rising focus on male infertility treatment:Male infertility is gaining more recognition in MEA as awareness improves and stigma declines. Clinics are increasingly offering advanced diagnostics and procedures like ICSI, which directly address sperm-related infertility. This growing focus reflects both lifestyle-related challenges in the Gulf and broader public health recognition of male factor infertility.

Fertility ServicesSegmentation



Surrogacy is the fastest growing procedure in the Middle East and Africa fertility services market because it offers a vital solution for couples unable to carry pregnancies and attracts cross-border patients from regions with restrictive laws.

The Middle East and Africa Fertility Services Market has seen surrogacy expand rapidly because it fills a gap for families facing medical, social, and legal barriers to parenthood. In Gulf societies, the cultural emphasis on large families and genetic continuity makes surrogacy appealing to couples where the woman cannot safely carry a pregnancy due to uterine scarring, repeated miscarriage, or medical complications. At the same time, surrogacy has gained traction among expatriates living in the UAE and other hubs who seek solutions in jurisdictions where the practice is legally available. Countries like South Africa allow regulated surrogacy, making it one of the few African destinations where intended parents, including international patients, can legally arrange the procedure under court oversight. The UAE, while conservative, has gradually adopted more progressive reproductive medicine practices, with certain clinics supporting surrogacy-related services under controlled frameworks, which has attracted patients from neighboring regions where it remains banned. Demand is also shaped by infertility rates that are rising due to conditions such as PCOS and delayed parenthood, both of which affect women significantly in the region. International patients from the wider Middle East, where surrogacy is legally restricted by religious law, often travel to destinations like South Africa, Georgia, or occasionally the UAE to access treatment. The visibility of high-profile cases and medical tourism marketing has helped normalize surrogacy despite cultural sensitivities. Combined with regional infertility prevalence, medical necessity, and the role of cross-border travel, surrogacy has become the fastest growing procedure within the Middle East and Africa Fertility Services Market.

Fresh non-donor services are the largest in the Middle East and Africa fertility services market because patients strongly prefer to use their own gametes to maintain genetic lineage, aligning with cultural and religious values.

The Middle East and Africa Fertility Services Market reflects fresh non-donor cycles as the dominant service because of cultural, religious, and personal preferences that prioritize biological parenthood. In societies across the Gulf, North Africa, and Sub-Saharan Africa, lineage and bloodline are highly valued, and couples strongly prefer treatments that use their own eggs and sperm. This preference aligns with Islamic and traditional cultural values, which often discourage or prohibit third-party donation, making donor programs less common compared to Europe or the Americas. Fresh cycles are especially popular because they use gametes retrieved and fertilized immediately, which patients often perceive as more natural and trustworthy than frozen alternatives. Clinics across the UAE, Saudi Arabia, and South Africa report that the majority of patients opt for fresh non-donor IVF or ICSI cycles, particularly younger couples with adequate egg reserves. The reliance on fresh cycles also stems from regulatory frameworks in many Middle Eastern countries that limit the use of donor gametes altogether, leaving fresh non-donor cycles as the only widely accepted option. From a clinical perspective, fresh cycles are effective when ovarian stimulation is well managed, and patients often prefer to attempt embryo transfer immediately after retrieval to reduce the emotional strain of waiting. Even in South Africa, where donor programs are legal and widely available, many patients still prefer to attempt pregnancy with their own gametes first. This religious acceptance, cultural emphasis on genetic continuity, and practical clinical outcomes explains why fresh non-donor remains the largest service in the Middle East and Africa Fertility Services Market.

Male infertility is the fastest growing cause in the Middle East and Africa fertility services market because lifestyle diseases, environmental factors, and delayed parenthood are increasingly affecting male reproductive health in the region.

The Middle East and Africa Fertility Services Market shows male infertility as the most rapidly expanding cause because new patterns of health and lifestyle are taking a toll on male reproductive capacity. Across Gulf states and parts of North Africa, obesity, diabetes, and hypertension have risen sharply, all of which negatively affect sperm production and hormonal balance. Smoking and high rates of tobacco use, including shisha and other forms, are also widespread and have been linked to reduced sperm motility and quality. Environmental stressors such as high temperatures, exposure to industrial pollutants, and pesticide-heavy agricultural work in certain African regions further weaken male reproductive health. At the same time, delayed marriage and childbearing in urban populations across the UAE, Saudi Arabia, and South Africa mean that men are trying to conceive later in life, when sperm quality naturally declines. Historically, infertility in the Middle East and Africa was often assumed to be a female problem, but growing awareness, increased use of semen analysis, and broader acceptance of male testing have revealed that male factor infertility accounts for a large share of cases. Fertility clinics in Dubai, Cape Town, and Cairo now routinely include advanced diagnostics and procedures such as intracytoplasmic sperm injection, which has become central in addressing severe male infertility. Public health organizations are beginning to highlight male reproductive health as an issue requiring more attention, which has further reduced stigma. With medical, environmental, and lifestyle pressures converging, male infertility has become the fastest growing cause category in the Middle East and Africa Fertility Services Market.

Hospitals are significant in the Middle East and Africa fertility services market because they combine fertility care with comprehensive medical treatment, which is crucial for patients facing complex infertility linked to other health conditions.

The Middle East and Africa Fertility Services Market continues to emphasize hospitals as key providers because they offer the integration of reproductive medicine with broader healthcare services. In many parts of the region, including Saudi Arabia, the UAE, and South Africa, hospitals are the primary point of access for couples seeking infertility evaluation, as they provide hormonal testing, imaging, and surgical treatments alongside IVF or ICSI procedures. Hospitals are especially important for patients with medical complications such as endometriosis, fibroids, or hormonal disorders like PCOS, which require both surgical and reproductive expertise. They also manage high-risk pregnancies and complications during fertility treatment, supported by intensive care units and multidisciplinary staff that smaller standalone clinics often lack. In Sub-Saharan Africa, large hospitals affiliated with universities or public health systems are often the only facilities with the infrastructure to run embryology labs or advanced ART programs, making them critical for accessibility. In the Gulf, hospitals combine fertility services with strong reputations for overall medical care, attracting both nationals and expatriates who want the assurance of safety and trust. Hospitals are also where many oncofertility services are offered, as cancer patients undergoing chemotherapy are counseled to preserve fertility before treatment. Their ability to bring together reproductive endocrinologists, urologists, surgeons, and psychologists under one system ensures that infertility is treated in a holistic way. For patients in regions where infertility is tightly linked to underlying medical conditions, hospitals remain significant players in the Middle East and Africa Fertility Services Market because they provide the comprehensive medical care that fertility alone cannot address.

Fertility Services Market Regional Insights


The United Arab Emirates leads the Middle East and Africa fertility services market because of its role as a medical tourism hub, advanced clinic infrastructure, and progressive approach to ART compared to regional peers.

The Middle East and Africa Fertility Services Market has the UAE at its forefront because the country has positioned itself as a global healthcare destination, and fertility medicine is a central part of this strategy. Dubai and Abu Dhabi host state-of-the-art fertility centers that attract patients not only from the UAE but also from across the Gulf, Africa, and South Asia, where access to advanced ART may be limited or restricted. The UAE has invested heavily in high-quality hospitals and specialized clinics, often in partnership with leading international fertility groups, ensuring that procedures such as IVF, ICSI, egg freezing, and donor services are available under world-class standards. The government has also adopted relatively progressive regulations compared to some neighboring states, permitting certain ART practices under strict oversight while balancing cultural and religious sensitivities. This regulatory flexibility makes the UAE one of the few countries in the region where both expatriates and nationals can access fertility services openly. The country’s strategic location and global connectivity make it a convenient hub for patients traveling from Africa, South Asia, and the wider Middle East, effectively creating a cross-border fertility tourism corridor. Rising infertility linked to lifestyle diseases, delayed marriage among both nationals and expatriates, and high prevalence of conditions such as PCOS further drive domestic demand. Moreover, the UAE’s emphasis on attracting medical professionals from around the world ensures that fertility clinics are staffed with experienced specialists and embryologists, giving patients access to international expertise without leaving the region. Cultural importance of family and the desire for children in Gulf societies reinforces willingness to pursue ART, often with strong family and financial support.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Discount offer

Table of Contents

  • Table 1: Global Fertility Service Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
  • Table 2: Influencing Factors for Fertility Service Market, 2024
  • Table 3: Top 10 Counties Economic Snapshot 2022
  • Table 4: Economic Snapshot of Other Prominent Countries 2022
  • Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 6: Middle East & Africa Fertility Service Market Size and Forecast, By Procedure (2019 to 2030F) (In USD Billion)
  • Table 7: Middle East & Africa Fertility Service Market Size and Forecast, By Service (2019 to 2030F) (In USD Billion)
  • Table 8: Middle East & Africa Fertility Service Market Size and Forecast, By Cause of Infertility (2019 to 2030F) (In USD Billion)
  • Table 9: Middle East & Africa Fertility Service Market Size and Forecast, By End User (2019 to 2030F) (In USD Billion)
  • Table 10: United Arab Emirates (UAE) Fertility Service Market Size and Forecast By Procedure (2019 to 2030F) (In USD Billion)
  • Table 11: United Arab Emirates (UAE) Fertility Service Market Size and Forecast By Service (2019 to 2030F) (In USD Billion)
  • Table 12: United Arab Emirates (UAE) Fertility Service Market Size and Forecast By Cause of Infertility (2019 to 2030F) (In USD Billion)
  • Table 13: United Arab Emirates (UAE) Fertility Service Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
  • Table 14: Saudi Arabia Fertility Service Market Size and Forecast By Procedure (2019 to 2030F) (In USD Billion)
  • Table 15: Saudi Arabia Fertility Service Market Size and Forecast By Service (2019 to 2030F) (In USD Billion)
  • Table 16: Saudi Arabia Fertility Service Market Size and Forecast By Cause of Infertility (2019 to 2030F) (In USD Billion)
  • Table 17: Saudi Arabia Fertility Service Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
  • Table 18: South Africa Fertility Service Market Size and Forecast By Procedure (2019 to 2030F) (In USD Billion)
  • Table 19: South Africa Fertility Service Market Size and Forecast By Service (2019 to 2030F) (In USD Billion)
  • Table 20: South Africa Fertility Service Market Size and Forecast By Cause of Infertility (2019 to 2030F) (In USD Billion)
  • Table 21: South Africa Fertility Service Market Size and Forecast By End User (2019 to 2030F) (In USD Billion)
  • Table 22: Competitive Dashboard of top 5 players, 2024

  • Figure 1: Global Fertility Service Market Size (USD Billion) By Region, 2024 & 2030
  • Figure 2: Market attractiveness Index, By Region 2030
  • Figure 3: Market attractiveness Index, By Segment 2030
  • Figure 4: Middle East & Africa Fertility Service Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
  • Figure 5: Middle East & Africa Fertility Service Market Share By Country (2024)
  • Figure 6: United Arab Emirates (UAE) Fertility Service Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
  • Figure 7: Saudi Arabia Fertility Service Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
  • Figure 8: South Africa Fertility Service Market Size By Value (2019, 2024 & 2030F) (in USD Billion)
  • Figure 9: Porter's Five Forces of Global Fertility Service Market

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%